4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Indaptus Therapeutics, Inc. (INDP) operates in the Biotechnology industry and is headquartered in New York, United States with about 5 employees. Its market capitalization is roughly $326 million. In the fiscal year ended 2025-12-31, INDP reported $0M in revenue and ($21M) in net income.
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($20M) | ($15M) | ($16M) | ($15M) | — |
| Net Income | ($21M) | ($15M) | ($15M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($8M) | ($3M) | ($4M) | ($5M) | — |
| Net Income | ($2M) | ($8M) | ($3M) | ($5M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $9M | $7M | $15M | $28M | — |
| Total Liabilities | $6M | $3M | $3M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INDP viewer.
About TickerBase · Data methodology & sources